Aflac Inc (AFL) stock
AFLNYSEAccident & Health InsuranceFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/306% above fair value
$127.61+1.10 (+0.87%)
Close on Nov 13, 2026Market cap $63.98BP/E 18.6Yield 1.82%
Aflac r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Aflac
Aflac has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?